Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision history was updated with the addition of Revision: v3.5.3 and the removal of Revision: v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an administrative versioning update rather than a content change.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded the keyword 'Tenosynovial giant cell tumor, diffuse type' and a 'Genetic and Rare Diseases Information Center' resource to the study page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study's recruitment status was updated to Active, not Recruiting, and the record shows Revision: v3.5.0 with recent update dates.SummaryDifference1%

- Check60 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded site revision tag 'Revision: v3.4.2'. Deleted items include a funding-status notice and the earlier 'Revision: v3.4.1' notice.SummaryDifference0.4%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.